single- vs double-unit transfusion for patients with hematological disorders
Published 5 months ago • 48 plays • Length 3:04Download video MP4
Download video MP3
Similar videos
-
1:29
updates from the energize study of mitapivat in non-transfusion-dependent alpha-/beta-thalassemia
-
3:17
estimating transfusion-related medical costs & time burden in patients with mf in simplify-1
-
2:21
unmet needs in lr-mds: rbc transfusion-dependence
-
2:09
past, present, and future management strategies for non-transfusion dependent β-thalassemia
-
1:46:07
hematology lecture
-
8:05
i took my own blood for a genetic test - the medical futurist
-
13:54
blood products - fresh frozen plasma (ffp), packed rbcs (prbc), cryoprecipitate, and more - hemato
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:23
the importance of myeloma-specific frailty indices in trial design
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
5:13
ukall2011: abl-class fusions & tkis
-
0:45
cys-ser mutation-driven ibrutinib resistance and alternative btki’s under development
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
39:27
medical grand rounds: transfusion medicine and using blood wisely
-
6:51
transfusion laboratory errors
-
1:06
key considerations when treating patients with cll who have pre-existing cardiovascular disease
-
2:41
an overview of the latest advances in hematology
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
2:19
secondary-type mutations do not impact the favorable prognosis in npm1-mutated aml
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study